BUGATTI, Antonella
 Distribuzione geografica
Continente #
EU - Europa 3.686
NA - Nord America 3.640
AS - Asia 1.128
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
SA - Sud America 5
AF - Africa 2
Totale 8.473
Nazione #
US - Stati Uniti d'America 3.627
PL - Polonia 2.437
CN - Cina 532
UA - Ucraina 394
DE - Germania 221
SG - Singapore 214
IT - Italia 173
HK - Hong Kong 147
FI - Finlandia 144
VN - Vietnam 89
GB - Regno Unito 80
TR - Turchia 75
IE - Irlanda 72
RU - Federazione Russa 65
FR - Francia 34
IN - India 28
ID - Indonesia 23
CZ - Repubblica Ceca 18
CA - Canada 12
BE - Belgio 11
SE - Svezia 11
EU - Europa 6
AU - Australia 5
ES - Italia 5
DK - Danimarca 3
NL - Olanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 8.473
Città #
Warsaw 2.436
Fairfield 549
Woodbridge 325
Houston 295
Ashburn 282
Jacksonville 282
Chandler 235
Cambridge 221
Seattle 209
Wilmington 195
Ann Arbor 191
Singapore 177
Hong Kong 147
Princeton 131
New York 102
Beijing 100
Dong Ket 87
Helsinki 87
Nanjing 83
Dublin 72
Brescia 71
Istanbul 65
Jinan 40
Nanchang 37
Shanghai 34
Boardman 32
Dearborn 30
Des Moines 29
San Diego 29
Hebei 28
Munich 28
Shenyang 27
Changsha 26
Jakarta 23
Moscow 19
Jiaxing 18
Tianjin 17
Phoenix 16
Brno 14
Lancaster 14
Los Angeles 14
Milan 14
Parma 13
Zhengzhou 13
Haikou 12
Hangzhou 12
Guangzhou 11
London 11
San Francisco 11
Verona 10
Toronto 9
Brussels 8
Kilburn 8
Kunming 8
Lanzhou 8
Norwalk 7
Taiyuan 7
Ningbo 6
Augusta 5
Fuzhou 5
Gunzenhausen 5
Leawood 5
Romola 5
San Mateo 5
Chicago 4
Espoo 4
Falkenstein 4
Hefei 4
Kocaeli 4
Lappeenranta 4
Orange 4
Taizhou 4
Canberra 3
Modena 3
Monmouth Junction 3
Olomouc 3
Padova 3
Ponte San Pietro 3
Sincan 3
Southwark 3
Udine 3
Amman 2
Amsterdam 2
Ardabil 2
Bergamo 2
Bloomington 2
Castiglione Delle Stiviere 2
Chisinau 2
Chiswick 2
Colombo 2
Delhi 2
Irmo 2
Marchiennes 2
New Bedfont 2
Ottawa 2
Prescot 2
Redwood City 2
Rezzato 2
Tappahannock 2
Villeurbanne 2
Totale 7.112
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 279
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 244
Biological role of immunoglobulin Free light chains interactomes 241
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 237
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 235
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 231
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 230
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 228
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 225
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 225
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 223
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 216
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 211
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 209
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 205
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 203
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 188
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 184
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 183
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 177
Chemoselective surface immbolization of proteins through a cleavable peptide 168
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 163
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 158
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 140
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 129
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 123
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 122
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 120
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 116
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 111
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 110
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 109
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 105
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 103
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 103
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 99
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 99
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 96
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 95
Positively charged peptides can interact with each other as revealed by solid phase binding assays 93
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 91
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 90
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 89
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 88
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 86
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 82
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 80
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 74
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 71
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 69
FGF2-Antagonist activity of long pentraxin-3 related peptides 67
FGF2- Antagonist activity of long pentraxin-3 65
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 61
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 58
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 56
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 55
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 55
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 55
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 55
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 53
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 53
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 51
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 51
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 43
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 43
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 36
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 34
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 32
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 32
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 26
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 22
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 19
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 18
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 18
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 10
Totale 8.624
Categoria #
all - tutte 36.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.498 0 0 0 0 0 253 211 239 197 331 130 137
2020/20211.586 59 144 63 200 87 166 118 202 155 155 114 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/2025488 15 9 11 226 108 119 0 0 0 0 0 0
Totale 8.624